Sign Up to like & get
recommendations!
0
Published in 2021 at "Organic letters"
DOI: 10.1021/acs.orglett.1c02374
Abstract: The alkaloid physostigmine is an approved anticholinergic drug and an important lead structure for the development of novel therapeutics. Using a complementary approach that merged chemical synthesis with pathway refactoring, we produced a series of…
read more here.
Keywords:
myxococcus xanthus;
physostigmines myxococcus;
mutasynthesis physostigmines;